In 2022, the Chinese pharmaceutical firm Innovent Biologics Inc. spent more than 2.8 billion yuan on research and development projects, representing a growth of more than 500 million yuan from the previous year. The core products of Innovent Biologics include anti-tumor medicines and drugs treating metabolic disorders and autoimmune diseases.
Research and development spendings of Innovent Biologics Inc. from 2019 to 2022
(in billion yuan)
Characteristic
R&D expenses in billion yuan
-
-
-
-
-
-
-
-
Exclusive Premium Statistic
To access all Premium Statistics, you need a paid Statista Account
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Innovent Biologics. (March 28, 2023). Research and development spendings of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) [Graph]. In Statista. Retrieved July 22, 2024, from https://www.statista.com/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/
Innovent Biologics. "Research and development spendings of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan)." Chart. March 28, 2023. Statista. Accessed July 22, 2024. https://www.statista.com/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/
Innovent Biologics. (2023). Research and development spendings of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan). Statista. Statista Inc.. Accessed: July 22, 2024. https://www.statista.com/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/
Innovent Biologics. "Research and Development Spendings of Innovent Biologics Inc. from 2019 to 2022 (in Billion Yuan)." Statista, Statista Inc., 28 Mar 2023, https://www.statista.com/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/
Innovent Biologics, Research and development spendings of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) Statista, https://www.statista.com/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/ (last visited July 22, 2024)
Research and development spendings of Innovent Biologics Inc. from 2019 to 2022 (in billion yuan) [Graph], Innovent Biologics, March 28, 2023. [Online]. Available: https://www.statista.com/statistics/1402043/chinese-pharmaceuticals-innovent-biologics-research-and-development-expenses/